Therapeutic resistance in breast cancer cells can result from deregulated EGFR signaling
Linda S. Steelman, William H. Chappell, Shaw M. Akula, Stephen L. Abrams, Lucio Cocco, Lucia Manzoli, Stefano Ratti, Alberto M. Martelli, Giuseppe Montalto, Melchiorre Cervello, Massimo Libra, Saverio Candido, James A. McCubrey
Topics & Concepts
Cancer researchProtein kinase BEpidermal growth factor receptorPTENCancerBreast cancerEstrogen receptorKinaseSignal transductionBiologyPI3K/AKT/mTOR pathwayChemistryMedicineInternal medicineCell biologyHER2/EGFR in Cancer ResearchCytokine Signaling Pathways and InteractionsMonoclonal and Polyclonal Antibodies Research